Wilkins / Williams / Nonplatinum / Plainum / Clinical Oncology / Philadelphia / London / Lippincott / /
Company
Martin Dunitz Ltd / Churchill Livingstone Inc. / Miller AB / /
Country
United States / /
Facility
Medical University / / /
IndustryTerm
chemotherapy protocols / Cancer Treat / cancer treatment / treatment of small cell lung cancer / treatment for small cell lung cancer / treatment of recurrent small cell lung cancer / /
MedicalCondition
disease progression / measurable metastatic disease / massive pleural effusion / active infections / leukopenia / interstitial pneumonia / Nausea / severe drug hypersensitivity / small cell lung cancer / overt cardiac disease / pulmonary fibrosis / recurrent disease remains / SCLC / refractory and sensitive disease / ipsilateral pleural effusions / stage disease / Patients developing disease / lung cancers / tumor / widely metastatic disease / SCLC cancer / common cancer / assessable disease / Measurable disease / cancer / tumors / disease / symptomatic brain metastases / progressive disease / neutropenia / cell lung cancer / fever / pain / vomiting / lung cancer / Survival INTRODUCTION Lung cancer / recurrent small cell lung cancer / Extensive disease / Objective tumor / distant metastases / anemia / primary tumor / /
Journal of IMAB - Annual Proceeding (Scientific Papers) vol. 16, book 3, 2010 OUR EXPERIENCE WITH TOPOTECAN AS SECOND- LINE TREATMENT OF PATIENTS WITH RELAPSED SMALL CELL LUNG CANCER Deyan Davidov,